Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
2
×
clinical trials
fda
life sciences
national blog main
agtechfood
alprazolam
amgen
antibodies
biologic drugs
boulder/denver
boulder/denver blog main
boulder/denver top stories
cgrp inhibitors
chronic migraine
clostridium difficile
colostrum
colucid pharmaceuticals
crohn's disease
cvs
cvs health
deals
diaresq
drug enforcement administration
drugs
eli lilly
fda warning letter
indiana
indiana blog main
indiana top stories
inflammatory bowel disease
investing
lasmiditan
mark braman
medical foods
microbiome
migraine research foundation
new york blog main
new york top stories
What
giving
2
×
acute
addresses
approval
babies
birth
born
breastfeed
causes
condition
days
decades
drug
eli
fda
friday
giant
gut
instructed
lands
lasmiditan
lilly
lilly’s
medication
microbiome
migraine
milk
mothers
new
oks
pantheryx
pharmaceutical
produce
reason
second
soon
target
there’s
they’re
use
Language
unset
Current search:
giving
×
biotech
×
" boston blog main "
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
